Migersi Medical Secures Tens of Millions in Series A1 Funding Led by Guangzhou Financial Holdings Fund

Investment Circle (ID: pedaily2012) May 20th, News: Recently, MIGERSI has officially completedTens of Millions of Yuan in A1 Round Financing. This round of financing was led byLed by Guangzhou Jinkong Fund Management co.,Ltd., with participation from Wuhan East Lake High Technology Equity Investment Management Co.,Ltd. ("East Lake Investment") and Guangzhou Yuefu Fund.

This round of funding will be used to complete the clinical trials of the glaucoma drainage tube and initiate the construction of the Guangzhou base.

MIGERSI, based on the active cationic polymer material (SIBS) technology platform, developed a glaucoma drainage tube with the following design intentions:

Simple

The injector is implanted via an external approach, with simple operation and accurate positioning. The surgery time is shorter, and patients recover faster.

Effective

The drainage tube has a larger inner diameter, making it more suitable for conditions in China; the SIBS material, with adjustable mechanical properties, exhibits excellent biostability and biocompatibility, significantly reducing postoperative inflammatory responses; implanted through a minimally invasive approach, it causes less trauma, minimal scarring around the drainage tube, and a sustained significant reduction in intraocular pressure.

Safety

The injector is designed with a limiting function, ensuring safety during the implantation process. After implantation, the long-term safety is supported by excellent material chemistry.

Currently, the clinical data of MIGERSI's glaucoma drainage tube has preliminarily demonstrated the aforementioned characteristics. With the support of new funding, the completion of clinical validation will be accelerated, and the construction of a new base will be initiated.

MIGERSI, founded in 2021, is an innovative medical device company focusing on minimally invasive ophthalmology, with active cationic polymer bio-materials technology as its source. The company owns a complete chain from materials to devices.